Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 8Breast Neoplasms 7Uterine Cervical Neoplasms 5Lung Neoplasms 5Hematopoietic and Lymphatic System Neoplasm 4Papillomavirus Infections 3Liver Neoplasms 2Hematologic Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma, Hepatocellular 2Pyloric Stenosis, Hypertrophic 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Overweight 1Obesity 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma 1Liver Diseases 1HER2+ Metastatic Breast Cancer (MBC) 1Fibrosis 1Diabetes Mellitus 1Colorectal Cancer Screening 1Colonic Neoplasms 1Cardiovascular Diseases 1Cancer Screening 1

Interventions

durvalumab 13Bevacizumab 11Nivolumab 10tremelimumab 7pembrolizumab 6lenvatinib 6fludarabine 6Cyclophosphamide 6atezolizumab 4Radiosurgery 4Cisplatin 4toripalimab 3relatlimab 3Magnetic Resonance Imaging 3Ipilimumab 3Gemcitabine 3X-Rays 2Standard of Care 2Sorafenib 2Riluzole 2Radiotherapy 2Photons 2Patient Navigation 2Lidocaine 2Hepatectomy 2Dexamethasone 2Biopsy 2trastuzumab deruxtecan 1tocilizumab 1tislelizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Liver Neoplasms × Patient Navigation × 1 year × Clear all
NCT06458998 2026-02-23

GTI

University of Pittsburgh

Phase NA Enrolling by invitation
30,300 enrolled
Gastrointestinal

Colonic Neoplasms, Fibrosis, Liver Neoplasms

NCT02312817 2025-07-15

RCT of Screening Strategies Among Patients at High Risk for Developing HCC in a Safety-net Health System

University of Texas Southwestern Medical Center

Phase NA Completed
1,800 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡